from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary: Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Dianthus Therapeutics, Inc. /DE/ Operating Lease, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $1,068,000.
Source SEC data: View on sec.gov

Operating Lease, Liability, Noncurrent, Quarterly (USD)

Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Liability, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,068,000	+$1,068,000		30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$1,119,000	+$1,089,000	+3630%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$1,170,000	+$1,073,000	+1106%	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	$1,171,000	+$1,003,000	+597%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$0	-$257,000	-100%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$30,000	+$30,000		30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$97,000	+$97,000		31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$168,000	-$270,000	-62%	31 Dec 2023	10-K	11 Mar 2025	2024	FY
Q3 2023	$257,000	-$26,920,000	-99%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$0	-$28,187,000	-100%	30 Jun 2023	10-Q	03 Aug 2023	2023	Q2
Q1 2023	$0	-$29,104,000	-100%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$438,000	+$438,000		31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	$27,177,000			30 Sep 2022	10-Q	03 Nov 2022	2022	Q3
Q2 2022	$28,187,000			30 Jun 2022	10-Q	04 Aug 2022	2022	Q2
Q1 2022	$29,104,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	8-K	21 Dec 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.